False claims: Pharma companies fined

MA said in its July–September quarterly report that the Code of Conduct committee dealt with allegations by Mundipharma that GSK’s promotional material on Seretide was false and misleading.

The committee said that while publishing fictitious patient quotes is itself a breach of the code, GSK had exacerbated its breach by placing the statements in quote marks beside the image of a young woman.

“GSK had agreed during intercompany dialogue to make clear that the statements were not from real patients,” the committee said.